baber/WOPTO huggingface dataset:
Patent JP-H10501628-A (JP)
IPC: G01N33/205
Filed: 1996-03-06
Abstract: PCT No. PCT/EP96/00952 Sec. 371 Date Oct. 18, 1996 Sec. 102(e) Date Oct. 18, 1996 PCT Filed Mar. 6, 1996 PCT Pub. No. WO96/32636 PCT Pub. Date Oct. 17, 1996The invention relates to a method to measure an electro-chemical activity of a non-metallic liquid layer lying on a molten bath by means of a measuring cell with an electro-chemical element which has an active part and with a counter electrode. The invention also relates to a measuring cell to measure an electro-chemical activity. In order to achieve exact measuring results of an electro-chemical activity with the least possible expenditure, the measuring cell is dipped through a non-metallic liquid layer into a molten bath, the active part of the electro-chemical element being surrounded by the non-metallic liquid layer of the material of this layer on insertion, this material being held at the electro-chemical element until after measuring the electro-chemical activity and the measurement being carried out after dipping the electro-chemical element into the molten metal within the molten bath. The electro-chemical element is especially developed to enable that the material to be measured adheres to it.
Patent JP-2001513875-A (JP)
Title: 電気アクチュエータ駆動段を試験する方法および回路
IPC: G01R31/00
Filed: 1997-02-26
Abstract: (57)【要約】
ＥＰＡＳシステムのモータ（１）のようなアクチュエータの駆動段（２）を試験する回路が装備されている。電源回路は、正常の駆動段電流を供給する接点（１６）と、正常の電流が供給される前に減少された駆動段電流を供給する抵抗器（３０）とを備えている。測定回路（３、２５、２６）は供給電圧のような駆動段電気パラメータを測定し、比較器（３）はこれと受容できる値と比較する。測定されたパラメータが駆動段（２）を通る期待値とは異なる電流に対応するならば、故障の信号が出され、接点（１６）が閉じるのを防止する。
Patent JP-2001510508-A (JP)
Title: 強磁性アモルファス金属合金及び焼き鈍し法
IPC: C22C45/02
Filed: 1998-02-03
Abstract: (57)【要約】
強磁性アモルファス金属合金のストリップを、鉄損ではなく、励磁力を最小限に抑えるように焼き鈍しする。このストリップは、６０Hzで測定したとき０．５VA/kg未満の励磁力、及び１．４０〜１．４５テスラの作用誘導を有する。ただし、それらの測定は周囲温度で行われる。このストリップから構成されるコアは、鉄損を最小限に抑えるように焼き鈍しされたものよりも高い作用誘導で作動させることができる。このコアを含めて、変圧器の磁気構成部材の物理的サイズは有意に小さくなる。
Patent JP-2000507818-A (JP)
IPC: A61P35/00
Filed: 1997-03-19
Abstract: A humanized specific monoclonal antibody or antibody fragment, especially a B-cell specific antibody or antibody fragment, is engineered to contain a glycosylation site in the non-Fc constant region. The glycosylated antibody is useful for diagnosis and/or therapy whenever a targeting antibody or fragment is used, especially for B-cell malignancies. The carbohydrate moiety allows conjugation of labeling or therapeutic agents of increased size, without affecting the binding affinity or specificity of the antibody.
Patent JP-2001511718-A (JP)
Title: インクジェット記録シート
IPC: C09D101/28
Filed: 1998-01-09
Abstract: (57)【要約】
本発明のインク受容組成物は、ａ）式（Ｉ）
 または式
 （式中、ｘは４０〜２００の整数であり、ｙは３〜１５の整数であり、ＰＥは式
 （式中、ｍは１〜４０までの整数であり、ｎは０〜４０−ｍの値であり、Ｚは水素または炭素原子数１〜１０のアルキル基である）を示す）を有する少なくとも１種の非イオン性シリコーン界面活性剤と、ｂ）ヒドロキシセルロースおよび置換ヒドロキシセルロースポリマーからなる群から選択される少なくとも１種のポリマーとを含み、基材に被覆され、少なくとも９０℃の温度に曝された場合に架橋可能であるインク受容組成物。
Patent JP-H11505256-A (JP)
Title: アセトニトリル類の製造方法
IPC: C07C253/08
Filed: 1996-05-16
Abstract: (57)【要約】
本発明は、ベンズアルデヒドの溶液にアルカリ金属の重亜硫酸化物を添加し、次いで、この混合物にアルカリ金属のシアン化物を添加することを特徴とする、水性媒質中でのベンズアルデヒドからシアノヒドリンへの転換方法に関する。該反応は、pＨ６.５〜７.５および０〜３０℃の温度で行われる。
Patent JP-2000508313-A (JP)
Title: 均一薬物投与療法
IPC: A61K9/52
Filed: 1997-03-20
Abstract: (57)【要約】
開示した発明は、作用剤製剤を含む、新規な投与系と、投与系から作用剤製剤を分配するための手段とに関する。
Patent JP-2000512658-A (JP)
IPC: A61Q19/08
Filed: 1998-03-03
Abstract: The present invention relates to a protection-effective amount of UV-damaged RNA fragments, in combination with a cosmetically or pharmaceutically acceptable carrier. The compositions are useful in the prevention of skin damage to UV radiation and in preventing photoaging.
Patent JP-2001514642-A (JP)
Title: ピラゾール誘導体の製造方法
IPC: C07D231/10
Filed: 1998-03-05
Abstract: (57)【要約】
本発明は、反応図式に従って、式（Ｉ）の化台物を式（ＩＩ）の化合物と反応させることによって、式（ＩＶ）［式中、Ｒ 3 、Ｒ 4 、Ｒ 6 、およびＡｒは、発明の説明に記載されているものと同意義である。］の化合物を製造する方法に関する。式（ＩＶ）の化合物は農薬として有用である。
Patent JP-2001504284-A (JP)
IPC: H04Q9/00
Filed: 1997-05-06
Abstract: A method for selecting an electronic module from a plurality of at least two modules (M1, M2, M3) capable of emitting messages simultaneously, includes the steps of sending a general query message (ACTIVALL) to the modules, and selecting (AFI, SELECT-ID) the module having responded first, the modules, on receiving a query message (ACTIVALL, ACTIV), determining a random time interval (P) and sending a responding message (ID, R) when the said time interval (P) has elapsed. A module is set in idle position (IDL) when it receives a message (MESS) before the time interval (P) preceding the sending of a response (ID, R) has elapsed. The idle position (IDL) is at least characterized by the fact that one module does not respond, subsequently, to a complementary query message (ACTIV). This invention is particularly useful for contactless smart card readers and for terminals for electronic labels.
Patent JP-2001508761-A (JP)
Title: 皮膚コンディションの改善方法
IPC: A61P17/00
Filed: 1997-05-13
Abstract: (57)【要約】
磁気ベクターポテンシャル場に曝され、かつ情報エネルギーを含む生理学上許容される支持層を皮膚に投与することによる、皮膚コンディションの改善方法。
Patent JP-2001525798-A (JP)
Title: 置換２−（３−アルケニルベンゾイル）シクロヘキサン−１，３−ジオン
IPC: C07C317/24
Filed: 1998-04-24
Abstract: (57)【要約】
本発明は、式Ｉ
 ［但し、Ｒ 1 とＲ 2 が、水素、ニトロ、ハロゲン、シアノ、チオシアナト、アルキル、ハロアルキル、アルコキシアルキル、アルケニル、アルキニル、−ＯＲ 6 、−ＯＣＯＲ 7 、−ＯＳＯ 2 Ｒ 7 、−ＳＨ、−Ｓ（Ｏ） n Ｒ 8 、−ＳＯ 2 ＯＲ 6 、−ＳＯ 2 ＮＲ 6 Ｒ 9 、−ＮＲ 9 ＳＯ 2 Ｒ 7 又は−ＮＲ 9 ＣＯＲ 7 を表し；Ｒ 3 が、水素、ハロゲン、アルキル、ハロアルキル、アルコキシ、アルケニル、アルキニルを表し；Ｒ 4 とＲ 5 は、水素、ニトロ、ハロゲン、シアノ、チオシアナト、アルキル、ハロアルキル、シクロアルキル、アルケニル、シクロアルケニル、アルキニル、アルコキシ、アルキルチオ、ハロアルコキシ、−ＣＯＲ 10 、−ＣＯ 2 Ｒ 10 、−ＣＯＳＲ 10 、−ＣＯＮＲ 10 Ｒ 11 、−Ｃ（Ｒ 12 ）＝ＮＲ 13 、−ＰＯ（ＯＲ 10 ）（ＯＲ 11 ）；無置換又は置換のアルキル、ヘテロシクリル、ヘテロシクリルアルキル、フェニル、フェニルアルキル、ヘテロアリール又はヘテロアリールアルキルを表し；或いはＲ 4 とＲ 5 が合体して、ヘテロ原子で置換されていても、及び／又は遮断されていても良いアルカンジイル鎖を形成し；Ｑが、無置換又は置換の２位に結合するシクロヘキサン−１，３−ジオン環である。］で表される２−（３−アルケニルベンゾイル）シクロヘキサン−１，３−ジオン及びその農業上有用な塩、式Ｉで表される化合物の製造方法、これらを含む組成物、及びこれらの誘導体又は望ましくない植物の制御のために化合物Ｉを含む組成物の使用法に関する。
Patent JP-2001525894-A (JP)
Title: 輪転グラビア印刷用紙を塗被するためのあられ石系沈降炭酸カルシウム顔料
IPC: D21H21/52
Filed: 1998-05-14
Abstract: (57)【要約】
本発明は輪転グラビア印刷用のコーティング顔料を塗被した紙、および該紙の調製法に関する。さらに、本発明は輪転グラビア印刷に有用な紙に塗被するためのあられ石系炭酸カルシウム顔料の調製法に関する。本発明は、また約３：１ないし約１５：１、好ましくは約４：１ないし約７：１のアスペクト比、および好ましくは２モードまたは３モードの多モード粒度分布を有する沈降炭酸カルシウム粒子に関する。好ましくは、該あられ石系沈降炭酸カルシウムは約２０ないし約１００重量パーセントの量で存在する。典型的には、該あられ石系沈降炭酸カルシウムは約４ないし約１５ｍ 2 ／ｇ、好ましくは約５ないし約７ｍ 2 ／ｇの比表面積を有する。本発明の沈降炭酸カルシウム顔料は二酸化チタン、タルク、か焼クレー、サチン白、プラスチック顔料、アルミニウム三水和物、マイカ、またはこれらの混合物とともに用いることもできる。他の有用な添加剤にはスチレン／ブタジエンまたはアクリル系結合剤のような合成ラテックス結合剤、デンプン共結合剤、メラミン／ホルムアルデヒド樹脂のようなデンプン不溶化剤、およびステアリン酸カルシウム潤滑剤が含まれる。
Patent MD-20000092-A (MD)
Title: Method of prognosticating the cardiac insufficiency syndrome evolution
Inventor: JUCOVSCHI CONSTANTIN
IPC: A61B5/02
Filed: 2000-05-26
Abstract: he invention refers to medicine, in particular to cardiology. Summary of the invention consists in that it is carried out the clinical and paraclinical examination of the patient, then according to the obtained data it is calculated the discriminating functions on the basis of which it is appreciated the variant of the cardiac insufficiency syndrome evolution.Claims: 1
Patent MD-20010065-A (MD)
Title: Suspension of a transport facility
Inventor: BOSTAN ION
IPC: B60G17/06
Filed: 2001-03-15
Abstract: The invention relates to the transport facilities, in particular to suspensions. The suspension includes cylinders (1, 2), fixed to the axes of the transport facility wheels, the rods (5, 6) of which are joined by means of two levers (7, 8) and of two unilateral overrunning clutches with the shafts of the precession differential gear (9), springs (3, 4). The driven shaft (10), onto which it is installed the flywheel (11), is connected to the shaft of the generator (12), supplying the storage battery (13). The vertical motions of the rods (5, 6) are transformed into pendular motions of the levers (7, 8). By means of the overrunning clutches these motions set into one-direction rotation the shafts of the differential gear (9), the turn-overs of which, being multiplied, are transmitted to the generator (12).Claims: 1Fig.: 2<IMAGE>
Patent MD-20070300-A (MD)
Title: Elementary solid body rotation process
Inventor: RASSOHIN ION
IPC: B43L11/00
Filed: 2007-11-05
Abstract: The invention relates to the field of mechanical engineering, particularly to the curve description devices and instruments.The nonuniform rotation mechanism comprises a solid body with a central through groove (2) and with a displaced hole for the pin (8) with head (9), a hub (6), on the front surface of which there are made a circular central grooving (7) and a displaced threaded hole (10). The solid body is freely fixed on the front surface of the hub (6) by means of a pin (11) with nut (13) and washer (12), placed by means of the through groove (2) into the displaced threaded hole (10) of the hub (6) and by means of a pin (8) with head (9). The leg of the pin (8) is fixed on the solid body, and its head is freely placed into the circular grooving (7) of the hub (6).
Patent MX-154549-A (MX)
Inventor: NOLA FRANK JOSEPH
IPC: G05F1/70
Filed: 1983-09-15
Abstract: A phase detector (16, 18, 20) is provided for use in a power factor controller for a three-phase induction motor. The power factor controller includes switching thyristors (10, 12, 14) for each motor phase winding and the phase detector for each phase includes an operational amplifier (A1) which senses the current phase angle for that phase by sensing the voltage across the phase thyristor. Common mode rejection is achieved by providing a positive feedback resistor (R5) between the input and output of the voltage sensing operational amplifier.
Patent NO-5987-A (NO)
Title: Fremgangsmåte for fremstilling av vinylsulfoksyder
Inventor: AIKINS JAMES A
IPC: C07C315/04
Filed: 2000-11-27
Abstract: Det er beskrevet nye diarylvenylsulfoksyder av formelen hvor RI er hydrogen, C i-C4 alkoksy, arylalkoksy, halogen eller amino; R2 er hydrogen, d-C4 alkoksy, arylalkoksy, halogen eller amino; og R3 er en termisk labil eller syrelabil C2-C10 alkyl, C4-Cio alkenyl eller aryl (d-Cl alkyl) gruppe. Det er videre beskrevet fremgangmåter for fremstilling av disse forbindelsene.
Patent NZ-211846-A (NZ)
Title: 2,3-diamino-2,3-didesoxyhexose derivatives and pharmaceutical compositions thereof
Inventor: MACHER I
IPC: C07D207/40
Filed: 1985-04-19
Abstract: PCT No. PCT/EP85/00171 Sec. 371 Date Dec. 18, 1985 Sec. 102(e) Date Dec. 18, 1985 PCT Filed Apr. 17, 1985 PCT Pub. No. WO85/04881 PCT Pub. Date Nov. 7, 1985.Compounds of formula I   <IMAGE> I  wherein R2 and R3 are the same or different and each represent unsubstituted or substituted acyl, and (a) R1 represents lower alkyl, aralkyl or the phosphate, pyrophosphate, phosphorylethanolamine or pyrophosphorylethanolamine group, R4 represents the phosphate, pyrophosphate, phosphorylethanolamine or pyrophosphorylethanolamine group and one of R1 and R4 may additionally represent hydrogen and R5 represents hydrogen or a glycosyl radical or (b) R1 represents hydrogen, lower alkyl or aralkyl and R4 and R5 represent hydrogen, which compounds are indicated for use as pharmaceuticals, in particular as immunostimulants.
Patent NZ-214979-A (NZ)
Title: Method for detecting htlv-iii
Inventor: ROBERT-GUROFF M
IPC: G01N33/569
Filed: 1986-01-30
Abstract: The invention relates to a method of measuring natural human antibodies in sera which will neutralize HTLV-III infection in an in vitro assay. Cell-free virus is incubated with serum and used to infect H9 cells, which are then put in a culture for three days. The viral infectivity is then assayed using a monoclonal antibody specific for HTLV-III p24 in an immune fluorescent assay.
Patent NZ-217026-A (NZ)
Title: Pyrimido (1,2-b) benzothiazole derivatives and pharmaceutical compositions
Inventor: ROWLANDS D A
IPC: C07D513/04
Filed: 1986-07-30
Abstract: The present invention relates to compounds of formula I   <IMAGE> [wherein R and R3,which may be the same or different, each represents a hydrogen atom or a straight-chained or branched C1-6 alkyl group or together with the intervening carbon atom represent a C3-6 cycloalkyl group; R1 represents a C7-12 straight-chained, branched or cyclic alkoxy group; and R2 represents a hydrogen atom, a straight-chained or branched C1-6 alkyl group, a C2-7 alkoxycarbonyl group, a C3-6 cycloalkyl group, an aralkyl group, an aryl group (unsubstituted or substituted by one or more halogen atoms or C1-6 alkyl, C1-6 alkoxy or nitro groups) or a heteroaryl group] and acid addition salts thereof, to processes for their preparation and to their application as drugs. Compounds 1 have anti-allergy activity.
Patent NZ-218732-A (NZ)
Title: Polysulphated oligosaccharide wound-healing compositions
Inventor: MICHAELI D
IPC: C07H11/00
Filed: 1986-12-19
Abstract: Pharmaceutical composition comprising sulfated oligosaccharides, particularly mono- and disaccharides, or their salts to enhance healing of wounds are described. Preferred saccharides are those having three or more sulfate groups, with persulfation being most preferred. Preferred salts are the soluble salts most preferably the alkali metal salts, particularly potassium and sodium salts. Sucrose octasulfate is the most preferred material. The saccharides may be present in any form, including liquids, gels or time release polymers. In preferred practice the saccharide is present in combination with collagen.
Patent NZ-237959-A (NZ)
Title: Protein or polypeptide with derivatised cysteine residue(s), pharmaceuticals and iodine or bromine containing reagents for their preparation
Inventor: BUCKWALTER BRIAN LEE
IPC: C07K1/107
Filed: 1991-04-26
Abstract: The present invention relates to physiologically-active derivatized natural and recombinant mammalian and human proteins and polypeptides. The invention provides chemical methods for derivatizing natural and recombinantly-derived proteins or polypeptides containing cysteine residues, either naturally or through site specific mutageneses. The pharmaceutical compositions containing said derivatized proteins and/or polypeptides are formulated to provide stable, long-acting compositions of such proteins and/or polypeptides, previously difficult to achieve.
Patent NZ-242597-A (NZ)
Title: Co-extruded water soluble laminated polymeric film and methods of extruding it
Inventor: VANPUTTE ANDREW
IPC: B32B27/08
Filed: 1992-05-04
Abstract: A water soluble film suitable for packaging caustic chemicals has an outer layer of a water soluble polymeric material, and an inner layer of a polymeric material which is compatible with the contents of a package made from the film. An intermediate layer can optionally be included to contribute to the tensile strength, bulk, or abuse resistance, or some other property of the film. Water soluble fillers such as salt can optionally be added to one or more of the polymeric materials, prior to or during extrusion of the film, to improve the processability of the film or its rate of dissolution in water, or to add a pigment to the film.
Patent NZ-251820-A (NZ)
Title: Fusion proteins with tnf-r (tumour necrosis factor-receptor) peptide linked to another tnf-r or an il-1r (interleukin-1-receptor) peptide
Inventor: SMITH CRAIG A
IPC: C12N15/28
Filed: 1993-03-26
Abstract: Fusion proteins comprise a tumour necrosis factor receptor (TNF-R) and an interleukin-1 receptor (IL-1R). The fusion proteins have therapeutic use and may be produced via recombinant DNA technology.
Patent NZ-266040-A (NZ)
Title: Rotating ridged drum type filter with pivoted scrapers guided between ridges to remove filter cake
Inventor: NILSSON HARRY
IPC: B01D33/21
Filed: 1994-05-04
Abstract: PCT No. PCT/SE94/00409 Sec. 371 Date Oct. 4, 1995 Sec. 102(e) Date Oct. 4, 1995 PCT Filed May 4, 1994 PCT Pub. No. WO94/25140 PCT Pub. Date Nov. 10, 1994A rotating filter including a container (11) for a liquid or suspension to be filtered and a rotor structure (17, 21, 22, 25, 26) being provided at its outer periphery with a filter medium arranged in the shape of at least one circular ring (33) having its center in the rotational axis of the rotor structure and an extension in the radial direction substantially from the outer circumference of the rotor structure. Removal and discharge means (73, 93) is arranged radially outside the outer periphery of the rotor structure, extends substantially thereto along the radial extension of the filter medium and is adapted to remove filter cake material from the filter medium and lead it radially outward towards the radially outer limit of the filter medium.
Patent NZ-301334-A (NZ)
Title: Helicobacter pylori antigen
Inventor: SMITH CHRISTOPHER JOHN
IPC: A61P31/04
Filed: 1996-02-15
Abstract: A novel antigen from H. pylori is provided. Its use in diagnosing H. pylori infection is also disclosed, including methods for said diagnosis, and kits for use in such a method. In addition, novel antigenic fragments of the antigen are provided, as well as vaccines comprising either the antigen or one or more antigenic fragments.
Patent NZ-315085-A (NZ)
Title: Testing printed circuit boards, two coplanar boards containing test needles movable with respect to each other
Inventor: VODOPIVEC JOZEF
IPC: G01R31/28
Filed: 1995-12-22
Abstract: A machine for testing printed circuit boards includes two coplanar boards 1SS, 1SD which have needles 10 protruding form one surface. The other end of the needles are connected to suitable test equipment. The free ends of the needles are brought into contact with a printed circuit board 2. One of the two boards is movable laterally with respect to the other, and the printed circuit board is also movable with respect to the boards 1SS, 1SD
Patent NZ-326610-A (NZ)
Title: Inhibitors of interleukin-1B or beta converting enzyme and use thereof
Inventor: BATCHELOR MARK J
IPC: A61P31/00
Filed: 1996-12-20
Abstract: The application relates to a classes of compounds which are inhibitors of interleukin-1'bconverting enzyme and are of the formula VI; where R1 is e10 or w2 and R2 is a ring of the formula  a or b. The application also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-c- mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases.
Patent NZ-333408-A (NZ)
Title: Methods for determining the presence of brain protein s-100
Inventor: BRUNDELL JAN
IPC: G01N33/543
Filed: 1997-06-27
Abstract: An assay method for determining the presence of the brain protein S-100 in a clinical sample which uses antibodies directed to epitopes in the region from ser1 to asn38 and from thr82 to glu93 of the amino acid sequence of the  beta  subunit of human S100B is provided.
Patent NZ-334239-A (NZ)
Title: Automatic control system for controlling firmness of air mattress
Inventor: SHAFER DAVID C
IPC: H04Q7/06
Filed: 1999-02-17
Abstract: This application relates to an automatic control system for controlling the firmness of a fluid supported mattress (14) of a bed assembly (10). The control system includes a motorized fluid pump, a control unit (44) for operating the pump to adjust the firmness of the air mattress (14), a hand held remote control unit (42) for actuating the control unit (44), and a transceiver system for transmitting information signals between the hand held unit (42) and the control unit (44).
Patent NZ-500767-A (NZ)
Title: Making a steel pin for axial, non-rotational penetration of a steel, concrete or masonry substrate
Inventor: OLVERA GILBERT
IPC: F16B43/00
Filed: 1998-12-14
Abstract: Described is a method of making a steel pin.  The method comprises: (i) forming a predetermined length of carbon steel wire into two parts, a head and a shank. (ii) Rolling the shank end to a point to form the pin and (iii) Heating the steel to harden it.
Patent NZ-501689-A (NZ)
Title: Air flow switching type air conditioner for both cooling and heating
Inventor: YUN MEYONG HYEK
IPC: F24F1/02
Filed: 1998-05-22
Abstract: An air flow switching type air conditioner for both cooling and heating has a compressor 4, condenser 3, an expansion valve 5 or capillary tube, an evaporator 2 and a refrigerant pipe 9 connecting those parts, as well as an air blower 10. The air conditioner specifically includes a case 1 which is so constructed that an indoor side discharge port 11 and an indoor side intake port 12, both parts being open to the inside of a room, as well as an outdoor side discharge port 13 and an outdoor side intake port 14, both parts being open to the outside, are separately partitioned by partition walls 25,26. A heat exchange chamber 20 which is formed between the indoor side discharge port 11 and indoor side intake port 12 and between the outdoor side discharge port 13 and outdoor side intake port 14 and in which the evaporator and the condenser are each disposed in a partitioned space, a first damper 31 provided between the evaporator 2 and the indoor side discharge port 11, a second damper 32 provided between the condenser 3 and the indoor side discharge port 11, a third damper 33 provided between the indoor side intake port 12 and the evaporator 2, a forth damper 34 provided between the indoor side intake port 12 and the condenser 3, a fifth damper 35 provided between the outdoor side discharge port 13 and the evaporator 2, a sixth damper 36 provided between the condenser 3 and the outdoor side discharge port 13, a seventh damper 37 provided between the outdoor side intake port 14 and the evaporator 2 and a eighth damper 38 provided between the outdoor side intake port 14 and the condenser 3, and wherein there is further included a controller by which the opening of the dampers is individually controlled.
Patent NZ-504730-A (NZ)
Title: Animal headstock gate with coacting vertical movement restraint bars
Inventor: FAGAN ROBIN CHRISTOPHER FELTRI
IPC: A01K15/04
Filed: 2000-05-24
Abstract: An animal head restraint is disclosed, as shown in figures 1A and 1B, comprising a head-bail assembly (2) - (5), headlock arms (6) and an actuation device. The restraint is characterized in that when operated, the head-bail doors (5) and the headlock arms (6) move simultaneously to restrain an animal, and prevent it from moving both horizontally and vertically.
Patent NZ-506163-A (NZ)
Title: Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
Inventor: HELLSTROM PER
IPC: A61K38/04
Filed: 1999-06-08
Abstract: Disclosed are pharmaceutical compositions comprising a gastrointestinal peptide hormone selected from glucagons-like peptide-1 (GLP-1) and derivatives thereof having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract. The compositions may include one or two more other gastrointestinal peptide hormones and derivatives. The compositions are used in the manufacture of medicaments for the treatment of functional dyspepsia and/or irritable bowel syndrome.